- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6869 - Methods for sequencing
Patent holdings for IPC class C12Q 1/6869
Total number of patents in this class: 6301
10-year publication summary
119
|
211
|
264
|
567
|
786
|
878
|
987
|
892
|
937
|
277
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Illumina, Inc. | 2771 |
428 |
Roche Sequencing Solutions, Inc. | 565 |
201 |
Illumina Cambridge Limited | 678 |
200 |
Life Technologies Corporation | 3068 |
145 |
Pacific Biosciences of California, Inc. | 738 |
140 |
Oxford NanoPore Technologies plc | 207 |
111 |
Guardant Health, Inc. | 312 |
97 |
The Regents of the University of California | 18943 |
93 |
President and Fellows of Harvard College | 5792 |
91 |
Quantum-Si Incorporated | 395 |
84 |
Natera, Inc. | 265 |
80 |
10X Genomics, Inc. | 921 |
75 |
Oxford NanoPore Technologies Limited | 297 |
72 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
69 |
F. Hoffmann-La Roche AG | 7958 |
57 |
Prognosys Biosciences, Inc. | 95 |
55 |
Singular Genomics Systems, Inc. | 210 |
54 |
The Broad Institute, Inc. | 1584 |
52 |
Ultima Genomics, Inc. | 158 |
51 |
The Trustees of Columbia University in the City of New York | 3440 |
48 |
Other owners | 4098 |